TL;DR
This study investigates the utility of different MRI signal intensities (liver parenchyma, spleen, and portal vein) and their ratios in assessing liver function in cirrhosis patients. The findings suggest that the liver-to-portal vein contrast ratio (LPC) is a more effective imaging biomarker for evaluating liver function severity than liver parenchyma or liver-to-spleen contrast ratios.
What Problem Does This Paper Address?
Accurately assessing liver function is crucial for managing patients with cirrhosis, as it guides treatment decisions and predicts prognosis. Current clinical methods, like the Child-Pugh and MELD scores, have limitations, including subjective components and an inability to assess localized liver function. While Gd-EOB-DTPA-enhanced MRI shows promise for evaluating liver function, there's a lack of consensus on which specific imaging parameters derived from this technique are most reliable. This paper aims to bridge this gap by systematically comparing the diagnostic performance of liver parenchyma, spleen, and portal vein signal intensities, as well as their derived contrast ratios, in reflecting liver function in cirrhosis.
Methods
The researchers conducted a retrospective analysis of 120 patients, including 41 healthy controls and 79 patients with varying stages of cirrhosis (Child-Pugh classes A, B, and C). All participants underwent Gd-EOB-DTPA-enhanced MRI. The study focused on the hepatobiliary phase (HBP) images taken 15 minutes post-contrast administration. Regions of Interest (ROIs) were placed on the liver parenchyma, spleen parenchyma, and portal vein to measure their signal intensities (SI). From these SIs, three contrast ratios were calculated: Liver-to-Portal Vein (LPC), Liver-to-Spleen (LSC), and Portal Vein-to-Spleen (PSC). Statistical analyses included comparisons of these MRI parameters across different Child-Pugh classes, correlation analyses with various laboratory liver function markers and clinical scores (Child-Pugh and MELD), and Receiver Operating Characteristic (ROC) curve analysis to assess their ability to differentiate between normal/mild cirrhosis and moderate/severe cirrhosis.
Datasets
The study utilized a dataset of 120 patients comprising:
- 41 normal subjects
- 79 patients with liver cirrhosis, further categorized into:
- HBV-related cirrhosis (n=52)
- HCV-related cirrhosis (n=13)
- Alcoholic cirrhosis (n=5)
- Schistosomal cirrhosis (n=9)
The data included clinical information, laboratory liver function tests, and Gd-EOB-DTPA-enhanced MRI scans. No new benchmark datasets were introduced.
Key Insights and Ideas
- LPC as a Superior Biomarker: The study strongly suggests that the Liver-to-Portal Vein Contrast Ratio (LPC) is a more sensitive and specific indicator of liver function severity in cirrhosis compared to liver parenchyma SI or LSC. This is likely because LPC integrates information from both the liver's uptake of the contrast agent and the portal vein's blood pool, offering a more comprehensive view.
- Portal Vein SI's Limited Role: Despite the portal vein's importance in liver circulation, its signal intensity alone (and the PSC ratio) did not show significant differences across cirrhosis severity groups, indicating it's not a reliable standalone marker for liver function in this context.
- Correlation with Clinical Scores: The MRI parameters, particularly LPC and LSC, showed significant negative correlations with established clinical scores like Child-Pugh and MELD, reinforcing their potential as imaging surrogates for these assessments.
- HBP Imaging's Value: The 15-minute hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI proves valuable for assessing liver function, offering a non-invasive method that can be integrated into routine imaging protocols.
Key Results
- Significant Differences: Liver parenchyma SI, LPC, and LSC showed significant gradual decreases from normal livers to Child-Pugh class C cirrhotic livers (p < 0.001).
- Portal Vein SI Trend: Portal vein SI showed a slight, non-significant increasing trend with increasing cirrhosis severity.
- Correlation Strength: LPC demonstrated a stronger correlation with Child-Pugh and MELD scores than LSC and liver parenchyma SI.
- ROC Analysis: The Area Under the Curve (AUC) for distinguishing between normal/Child-Pugh A and Child-Pugh B/C groups was highest for LPC (0.892), followed closely by LSC (0.889), and then liver parenchyma SI (0.836). While differences in AUCs were not statistically significant, LPC showed the best performance.
- Optimal Cut-off Values: The study identified optimal cut-off values for LPC (1.20) and LSC (1.27) for differentiating between groups.
Limitations and Future Work
The authors acknowledge several limitations:
- Lack of Biopsy Confirmation: Cirrhosis severity was not grouped based on liver biopsy results, which is the gold standard.
- Heterogeneous Etiologies: The study did not classify cirrhosis by cause (e.g., viral, alcoholic), which could influence contrast uptake and excretion patterns.
- Retrospective Design: The retrospective nature of the study may introduce selection bias.
- Limited Child-Pugh C Patients: A small number of patients with Child-Pugh class C disease were included due to their poor physical condition, limiting the generalizability of findings for this severe stage.
Future work should involve prospective, multicenter studies with larger cohorts of severe cirrhosis patients and classification by etiology. The authors also plan to investigate segmental liver function, which is clinically more relevant than whole-liver function assessment.
Summary updated